Lactate dehydrogenase as a prognostic factor for survival time of terminally ill cancer patients: A preliminary study
- 1 April 2007
- journal article
- Published by Elsevier in European Journal of Cancer
- Vol. 43 (6) , 1051-1059
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Lactate dehydrodgenase levels predict pulmonary morbidity after lung resection for non-small cell lung cancerEuropean Journal of Cardio-Thoracic Surgery, 2004
- A systematic review of physicians' survival predictions in terminally ill cancer patientsBMJ, 2003
- Prognostic Factors in Pancreatic CarcinomaAmerican Journal of Clinical Oncology, 2001
- Measurement of the Systemic Inflammatory Response Predicts Cancer-Specific and Non-Cancer Survival in Patients With CancerNutrition and Cancer, 2001
- Elevated Serum Vitamin B12 Levels Associated With CRP as a Predictive Factor of Mortality in Palliative Care Cancer PatientsJournal of Pain and Symptom Management, 2000
- Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study Commentary: Why do doctors overestimate? Commentary: Prognoses should be based on proved indices not intuitionBMJ, 2000
- The relative accuracy of the clinical estimation of the duration of life for patients with end of life cancerCancer, 1999
- Assessing the Generalizability of Prognostic InformationAnnals of Internal Medicine, 1999
- Biological indices predictive of survival in 519 Italian terminally Ill cancer patientsJournal of Pain and Symptom Management, 1997
- Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base.Journal of Clinical Oncology, 1990